LDHA activity inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11142520
APP PUB NO 20200165233A1
SERIAL NO

16613837

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of formula (I), stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof: (I) wherein A1 to A6 and R1 to R4 are as defined herein. Such compounds are suitable for use in the treatment or prevention of diseases or conditions which are mediated by the activation of lactate dehydrogenase A (LDHA), for example cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARCTIC PHARMA AS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bøen, Claudia Alejandra Oslo, NO 3 2
Hnida, Kathrin Oslo, NO 3 2
Klaveness, Jo Oslo, NO 187 4245
Lundvall, Steffi Oslo, NO 4 2
Sieng, Bora Oslo, NO 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 12, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 12, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 12, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00